Decoding the Biological Diversity (Amendment) Act, 2023: A New Paradigm for India's Bio-Economy?

In a move that has ignited a fierce debate across India’s environmental, industrial, and indigenous rights sectors, the Parliament passed the Biological Diversity (Amendment) Act, 2023. This legislation fundamentally overhauls the foundational Biological Diversity Act of 2002, a law originally enacted to domesticate the principles of the United Nations Convention on Biological Diversity (CBD). The 2002 Act was celebrated globally as a pioneering framework for ensuring the conservation of biodiversity, its sustainable use, and, most critically, the fair and equitable sharing of benefits arising from the use of biological resources and associated traditional knowledge—a principle famously known as Access and Benefit Sharing (ABS).

The stated purpose of the 2023 amendment is to simplify, streamline, and decriminalize the compliance process, thereby encouraging more investment and research in India’s burgeoning bio-economy, particularly within the AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homoeopathy) sector. Proponents argue that the original Act was cumbersome, stifling innovation and preventing India from capitalizing on its immense biological wealth. However, critics, including numerous environmental law experts, conservation scientists, and community rights advocates, contend that the amendments represent a significant dilution of the 2002 Act’s conservationist and equity-focused ethos. They argue that in the pursuit of ‘ease of doing business,’ the new law prioritizes commercial interests over the rights of local and indigenous communities who have been the traditional custodians of this biodiversity and knowledge. This article provides a comprehensive, analytical deep-dive into the provisions of the 2023 Amendment, its geopolitical and economic drivers, the major points of contention, and its far-reaching implications for India’s environmental governance.

Fun Fact: India is one of the world’s 17 “megadiverse” countries, harboring an estimated 7-8% of all recorded species on Earth, including over 45,000 plant species and 91,000 animal species, all within just 2.4% of the world’s land area. This incredible biological richness is the very resource at the heart of the Biological Diversity Act.

The Original Framework: The Biological Diversity Act, 2002 and the Nagoya Protocol

To understand the significance of the 2023 amendments, one must first appreciate the architecture of the parent Act. The Biological Diversity Act, 2002 was a direct response to India’s obligations under the CBD. Its soul was the principle of Access and Benefit Sharing (ABS), which was later codified globally through the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization, which India ratified in 2014. This was designed to counteract Biopiracy, where foreign corporations would patent traditional knowledge or genetic resources without compensating the source country or community.

The 2002 Act established a three-tiered structure to regulate access to biological resources:

1. National Biodiversity Authority (NBA): A statutory body headquartered in Chennai, acting as the central regulator and advisory body. It was responsible for approving access for foreign entities (individuals and corporations), transferring research results, and granting intellectual property rights (IPR) based on Indian biological resources.
2. State Biodiversity Boards (SBBs): Established in each state, these bodies were responsible for advising state governments and managing access to resources for domestic Indian entities and individuals for commercial purposes.
3. Biodiversity Management Committees (BMCs): Constituted by local bodies (Panchayats, Municipalities), these were the grassroots institutions. Their primary mandate was to promote conservation, sustainable use, and documentation of biodiversity. Crucially, they were tasked with creating People’s Biodiversity Registers (PBRs), detailed local inventories of biological resources and associated traditional knowledge. The NBA and SBBs were required to consult the relevant BMC before granting any access approval.

The core mechanism was a combination of Prior Informed Consent (PIC) from the NBA or SBBs before accessing any biological resource for research or commercial use, and Mutually Agreed Terms (MAT), which were legal agreements that would dictate how the monetary and non-monetary benefits (e.g., royalties, technology transfer, joint R&D) would be shared with the benefit claimers, often channeled through the BMCs. The Act had strong punitive measures, including criminal penalties and imprisonment of up to five years, for non-compliance.

The 2023 Amendment: A Paradigm Shift Towards Commerce

The Biological Diversity (Amendment) Act, 2023, introduces several profound changes that recalibrate the balance between conservation, community rights, and commercial exploitation.

1. Decriminalization of Offences: Perhaps the most significant change is the decriminalization of violations. Under the 2002 Act, offenses like biopiracy or accessing resources without approval could lead to imprisonment. The 2023 Amendment replaces these criminal penalties with monetary fines, ranging from ₹1 lakh to ₹1 crore, with penalties potentially higher if the gains from the violation exceed this amount. The power to determine the penalty is vested in a government-appointed Adjudicating Officer (of the rank of Joint Secretary or higher).

• Argument for: Proponents, including the government and industry bodies, argue that the threat of imprisonment was a major deterrent for researchers and companies, creating a climate of fear that stifled R&D. They claim that hefty financial penalties are a sufficient deterrent and align with a broader government policy of decriminalizing minor economic offenses.
• Argument Against: Critics argue that for large multinational corporations, these fines are merely an operational cost, a “price of doing business.” They believe that decriminalization removes the moral and ethical weight of the offense, effectively encouraging a ‘pay and pollute’ or ‘pay and pirate’ mindset and weakening the Act’s deterrent power against biopiracy. The fear of criminal prosecution, they argue, was a more potent check than a fine that can be factored into a project’s budget.

2. Exemption for AYUSH Practitioners and Companies: The amendment introduces a broad exemption for registered AYUSH practitioners and companies using “codified traditional knowledge.” These entities will no longer be required to seek prior approval from State Biodiversity Boards for accessing biological resources. The term “codified traditional knowledge” is contentious, as it is interpreted to include knowledge already documented in classical texts (like Charaka Samhita) and official pharmacopoeias.

• Argument for: The AYUSH ministry and industry argued that the approval process was an unnecessary burden on traditional medicine practitioners and the rapidly growing Indian wellness industry. They claim it will fast-track research, encourage more practitioners to use traditional formulations, and boost the ‘Make in India’ initiative.
• Argument Against: This is the most fiercely contested provision. Opponents argue it creates a massive loophole. A large company can now access a biological resource (e.g., a specific herb from a specific forest), claim it is for a use based on “codified” knowledge, and completely bypass the benefit-sharing mechanism with the local communities who may have been the primary conservers of that resource and its unique local variant. It effectively negates the role of Biodiversity Management Committees (BMCs) in this context and ignores the fact that “codified” knowledge is often kept alive and adapted by local practice.

3. Narrowing the Scope of Access and Benefit Sharing (ABS): The amendment significantly refines the definition of who is obligated to engage in benefit sharing. While the 2002 Act applied broadly, the 2023 amendment focuses the ABS obligation primarily on foreign-controlled companies, foreign citizens, and non-resident Indians. While Indian companies are still required to register with the SBBs, the explicit linkage to benefit sharing for domestic companies has been made more ambiguous. Furthermore, the Act encourages investment in research and the bio-economy, and the term “benefit sharing” is now often interpreted as reinvestment into corporate R&D or conservation efforts, rather than direct monetary sharing with local communities.

Analogy: Imagine a family owns a large, ancient orchard (traditional knowledge and biodiversity). The 2002 Act said anyone who wanted to pick fruit to sell commercially (even a cousin from the same village) had to ask permission and share a portion of the profits with the family. The 2023 Amendment says that only outsiders (foreign companies) need to ask and share profits. The cousins (domestic/AYUSH companies) can now pick the fruit freely, promising to use some of their profits to plant more trees in the orchard later, but they don’t have to give any money directly to the family.

4. Boosting Foreign Investment: The Act explicitly aims to attract more foreign investment in the biodiversity sector. By simplifying compliance, removing the threat of criminal prosecution, and clarifying the approval process for foreign entities (while still keeping them under the purview of the National Biodiversity Authority), the government hopes to make India a more attractive destination for research, development, and manufacturing based on biological resources.

To remember the key areas of change in the 2023 Amendment, you can use the mnemonic DEAF:

Mnemonic: “Decriminalize, Exempt AYUSH, Attract Foreign Investment”

Comparative Analysis: 2002 Act vs. 2023 Amendment

Critical Policy Appraisal

| Challenges / Criticisms | Opportunities / Successes / Way Forward | | :--- | :--- | :--- | | Dilutes the core principle of Access and Benefit Sharing (ABS) enshrined in the Nagoya Protocol. | May stimulate investment and R&D in the AYUSH and biopharmaceutical sectors. | | Marginalizes the role of local communities and Biodiversity Management Committees (BMCs). | Simplifies and streamlines the compliance framework, reducing bureaucratic hurdles for researchers. | | Decriminalization may weaken the deterrent against biopiracy by large corporations. | Aims to position India as a global hub for bio-economy and sustainable product development. | | The term “codified traditional knowledge” creates a significant loophole, excluding communities. | Could lead to faster development of new drugs and wellness products based on Indian biodiversity. | | Prioritizes commercial interests over conservation and equity, a departure from the original Act’s spirit. | The focus on monetary penalties could, if implemented robustly, create a fund for conservation activities. |

Staggering Statistic: The global market for traditional medicine, in which India’s AYUSH sector is a major player, is projected to reach nearly $400 billion by 2028. The 2023 amendment is strategically positioned to help Indian companies capture a larger share of this lucrative market.

Analytical Lens: UPSC Focus (Mains & Prelims)

Conceptual Basis

The legal and ethical backbone of this topic rests on the UN Convention on Biological Diversity (CBD, 1992) and its supplementary agreement, the Nagoya Protocol on Access and Benefit Sharing (2010). The original Biological Diversity Act, 2002 was India’s domestic legislation to enforce these international commitments. The 2023 Amendment must be analyzed in the context of whether it still upholds the spirit of these international treaties, particularly the emphasis on “fair and equitable” benefit sharing with indigenous and local communities.

UPSC Integration: Connecting the Dots

This topic is a classic example of the complex, interdisciplinary issues favored by UPSC.

• GS Paper 3 (Environment & Economy): This is the primary locus. It directly involves environmental conservation, government policies, changes in industrial policy, and the concept of a bio-economy. The conflict between environmental regulation and economic growth is a core theme.
• GS Paper 2 (Polity, Governance & Social Justice): The amendment touches upon the legislative process, the functioning of statutory bodies (NBA, SBBs), the rights of tribal and local communities (a social justice issue), and the federal structure (role of state vs. center). It also connects to the Forest Rights Act, 2006, and the powers of Gram Sabhas.
• GS Paper 4 (Ethics): The debate involves ethical considerations of corporate responsibility, the rights of indigenous knowledge holders, and the principle of distributive justice. Is it ethical to prioritize corporate profit over the traditional rights of communities? This can be framed as a conflict between utilitarian (greatest economic good) and deontological (duty to protect rights) ethics.

Future Impact and Policy Relevance

The long-term impact of the Biological Diversity (Amendment) Act, 2023, will be a critical test of India’s development model. If the government’s vision succeeds, it could unlock immense economic value, create jobs, and lead to scientific breakthroughs, with some benefits trickling down into conservation. However, if the critics’ fears are realized, it could lead to the rampant commercialization and potential exhaustion of biological resources with little to no benefit reaching the communities who have protected them for centuries. This would not only be a social injustice but also a poor conservation strategy, as community participation is globally recognized as essential for long-term environmental protection. The future trajectory will depend heavily on the rule-making process and the robustness with which the remaining regulations are enforced.

Prelims Practice Question (MCQ)

Question: With reference to the Biological Diversity (Amendment) Act, 2023, consider the following statements:

1. It replaces criminal penalties for all offenses under the Act with a system of civil fines.
2. It mandates that foreign companies must share a minimum of 50% of their profits with local Biodiversity Management Committees (BMCs).
3. It exempts AYUSH practitioners from the requirement of seeking prior approval from State Biodiversity Boards for using codified traditional knowledge.

Which of the statements given above is/are correct? (a) 1 and 2 only (b) 3 only (c) 1 and 3 only (d) 1, 2 and 3

Answer: (c) Explanation:

• Statement 1 is correct. The amendment decriminalizes the offenses and replaces imprisonment with monetary penalties.
• Statement 2 is incorrect. The Act does not specify a fixed percentage like 50%. The terms of benefit sharing are to be determined on a case-by-case basis through “mutually agreed terms” (MAT), and the amendment’s focus has shifted away from direct monetary sharing.
• Statement 3 is correct. This is one of the most significant and controversial changes introduced by the 2023 Amendment, aimed at promoting the AYUSH industry.

Mains Sample Question

Question (15 Marks): “The Biological Diversity (Amendment) Act, 2023, attempts to strike a balance between ‘ease of doing business’ and the conservation principles of the Nagoya Protocol, but critics argue it tilts heavily in favor of the former.” Critically evaluate this statement, highlighting the key provisions of the amendment and their potential impact on the rights of local communities. (250 words)

Mind Map Outline (Revision Structure)

• Biological Diversity (Amendment) Act, 2023
  • Context: Overhauling the 2002 Act
    • Original Act (2002): Based on UN CBD and Nagoya Protocol.
      • Core Principle: Access and Benefit Sharing (ABS).
      • Structure: NBA, SBBs, BMCs.
      • Mechanism: Prior Informed Consent (PIC) & Mutually Agreed Terms (MAT).
      • Focus: Conservation and Community Rights.
  • Key Provisions of the 2023 Amendment
    • Decriminalization:
      • Replaced imprisonment with monetary fines.
      • Arguments For: Reduces researcher fear, promotes business.
      • Arguments Against: Weakens deterrent for corporations, makes biopiracy a “cost of business”.
    • Exemption for AYUSH Sector:
      • No prior approval for “codified traditional knowledge.”
      • Criticism: Creates a major loophole, bypasses community benefit sharing, ambiguity of “codified”.
    • Narrowing ABS Scope:
      • Focus on foreign entities.
      • Ambiguity for domestic firms.
      • Shift from direct community payments to reinvestment.
    • Promoting Foreign Investment:
      • Streamlining processes to attract capital.
  • Core Debate: Conservation vs. Commerce
    • Proponents’ View:
      • Boosts bio-economy and AYUSH sector.
      • Simplifies compliance (‘Ease of Doing Business’).
      • Fosters R&D and innovation.
    • Critics’ View:
      • Dilutes Nagoya Protocol’s spirit.
      • Marginalizes local communities and BMCs.
      • Prioritizes profit over conservation and equity.
  • UPSC Analytical Framework
    • Conceptual Basis:
      • UN Convention on Biological Diversity (CBD).
      • Nagoya Protocol on ABS.
      • Domestic Law: Biological Diversity Act, 2002.
    • Syllabus Integration:
      • GS-3: Environment, Economy, Bio-economy, Science & Tech.
      • GS-2: Governance, Legislation, Social Justice (Tribal Rights), Federalism.
      • GS-4: Environmental and Corporate Ethics, Utilitarianism vs. Deontology.
    • Impact Analysis:
      • Potential for economic growth vs. risk of biopiracy and community disenfranchisement.
      • Future depends on robust rule-making and enforcement. [NEW_TOPIC_NAME:decoding-biological-diversity-amendment-act-2023]